Vojtěch Novotný

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Nicola Logallo, Vojtěch Novotný, Christopher Elnan Kvistad et al. · The Lancet Neurology · 2017 · 458 citations

Thrombosis, Endpoint Trial, Tenecteplase Versus Alteplase +13

Recurrent ischemic stroke: Incidence, predictors, and impact on mortality

Andrej Netland Khanevski, Anna Therese Bjerkreim, Vojtěch Novotný et al. · Acta Neurologica Scandinavica · 2019 · 168 citations · Full text

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Acute cerebral infarcts in multiple arterial territories associated with cardioembolism

Vojtěch Novotný, Lars Thomassen, Ulrike Waje‐Andreassen · Acta Neurologica Scandinavica · 2016 · 35 citations

Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke

Christopher Elnan Kvistad, Vojtěch Novotný, Martin Kurz et al. · Stroke · 2019 · 35 citations · Full text

Severe Ischemic Stroke, Cerebrovascular Disease, Thrombosis +21